Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Inotiv, Inc. Director's Dealing 2010

May 14, 2010

34595_dirs_2010-05-14_fc483149-649b-43a1-a05a-59622741ed97.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOANALYTICAL SYSTEMS INC (BASI)
CIK: 0000720154
Period of Report: 2010-05-12

Reporting Person: Chilton Anthony S (Director, CEO and President)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2010-05-12 Option to purchase common shares $.99 A 125000 Acquired 2020-05-12 Common Stock (125000) Direct

Footnotes

F1: The option is exercisable in three equal annual installments beginning on January 31, 2011.